Open Access

[Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway

  • Authors:
    • Jixing Fu
    • Jianhua Zhao
    • Huamin Zhang
    • Xiaoli Fan
    • Wenjun Geng
    • Shaohua Qiao
  • View Affiliations

  • Published online on: May 13, 2024     https://doi.org/10.3892/etm.2024.12568
  • Article Number: 280
  • Copyright : © Fu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

July-2024
Volume 28 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fu J, Zhao J, Zhang H, Fan X, Geng W and Qiao S: [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway. Exp Ther Med 28: 280, 2024.
APA
Fu, J., Zhao, J., Zhang, H., Fan, X., Geng, W., & Qiao, S. (2024). [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway. Experimental and Therapeutic Medicine, 28, 280. https://doi.org/10.3892/etm.2024.12568
MLA
Fu, J., Zhao, J., Zhang, H., Fan, X., Geng, W., Qiao, S."[Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway". Experimental and Therapeutic Medicine 28.1 (2024): 280.
Chicago
Fu, J., Zhao, J., Zhang, H., Fan, X., Geng, W., Qiao, S."[Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway". Experimental and Therapeutic Medicine 28, no. 1 (2024): 280. https://doi.org/10.3892/etm.2024.12568